End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,499,232 | 37,481 ( 2.500 %) | 0 | 2.500 % |
Stock B | 0 | 78,768 | 0 | 0 |
Company contact information
Poniard Pharmaceuticals, Inc.
300 Elliott Avenue West Suite 530
98119, Seattle
+
![address Poniard Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/9496833.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+6.96% | 10TCr | |
+8.29% | 4.26TCr | |
-11.09% | 3.35TCr | |
+82.32% | 2.98TCr | |
-11.82% | 1.61TCr | |
+1.39% | 1.43TCr | |
-12.13% | 1.15TCr | |
+176.65% | 1.05TCr | |
+6.74% | 919.73Cr |
- Stock Market
- Equities
- PARD Stock
- Stock
- Company Poniard Pharmaceuticals, Inc.